Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Glucocorticoid Sparing Effect in Patients Receiving RoActemra® for Rheumatoid Arthritis in Real Life.

NCT01392001 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01392001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01392001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Glucocorticoid Sparing Effect in Patients Receiving RoActemra® for Rheumatoid Arthritis in Real Life.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2013
Enrollment
322 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis